Dong-Gu Biopharm to Collaborate with Pelmore and Link Korea on Next-Generation Drug Delivery Technology
Predicted impact: Low· Actual: −6.0% vs sector, volume 1.0× normal (5 trading days)
006620 · KOSDAQ · ₩006620 · 동구바이오제약
Predicted impact: Low· Actual: −6.0% vs sector, volume 1.0× normal (5 trading days)
Predicted impact: Low· Actual: −6.0% vs sector, volume 1.0× normal (5 trading days)
Three-way drug delivery tech partnership; no financial terms disclosed
Also known as: DongKoo Bio & Pharma / 동구바이오제약 / 006620 / KRX:006620
Source: KRX statistical information